Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom

Conditions

• Healthy Volunteers (Meningococcal Infection)

Interventions

• BIOLOGICAL: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine
• BIOLOGICAL: Meningococcal group B vaccine
• BIOLOGICAL: Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated) vaccine
• BIOLOGICAL: Human rotavirus RIX4414 strain vaccine
• BIOLOGICAL: Pneumococcal 13-valent polysaccharide conjugate vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company